| Literature DB >> 30449449 |
Shirin Mollazadeh1, Amirhossein Sahebkar2, Farzin Hadizadeh3, Javad Behravan4, Sepideh Arabzadeh5.
Abstract
P-glycoprotein (P-gp) is a member of ATP-binding cassette (ABC) superfamily which extrudes chemotherapeutic agents out of the cell. Suppression of this efflux activity has been the subject of numerous attempts to develop P-gp inhibitors. The aim of this review is to present up-to-date information on the structural and functional aspects of P-gp and its known inhibitors. The data presented also provide some information on drug discovery approaches for candidate P-gp inhibitors. Nucleotide-binding domains (NBDs) and drug-binding domains (DBDs) have been extensively studied to gain more information about P-gp inhibition and it looks that the ATPase activity of this pump has been the most attractive target for designing inhibitors. Hydrophobic and π-π (aromatic) interactions between P-gp binding domains and inhibitors are dominant intermolecular forces that have been reported in many studies using different methods. Many synthetic and natural products have been found to possess inhibitory or modulatory effects on drug transporter proteins. Log P value is an important factor in studying these inhibitors and has a crucial role on absorption, distribution, metabolism, and excretion (ADME) properties of candidate P-gp inhibitors.Entities:
Keywords: Drug transporter; Inhibitor; Multidrug resistance; P-glycoprotein
Mesh:
Substances:
Year: 2018 PMID: 30449449 DOI: 10.1016/j.lfs.2018.10.048
Source DB: PubMed Journal: Life Sci ISSN: 0024-3205 Impact factor: 5.037